Developing treatments for rare diseases pose many unique challenges that cannot be addressed by traditional study designs, including:
1) Prolonged enrolment periods and/or inability to enroll enough patients to formally power trials
2) Lack of clarity regarding endpoints and key design assumptions due to limited relevant clinical trials experience
3) Ethical concerns around the inclusion of a control arms.
These challenges require novel approaches, several of which will be reviewed and discussed during this webinar.